These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 38973398)
1. Exogenous glucocorticoids to improve extinction learning for post-traumatic stress disorder patients with hypothalamic-pituitary-adrenal-axis dysregulation: a study protocol description. de Nooij L; Wirz L; Heling E; Pais M; Hendriks GJ; Verkes RJ; Roozendaal B; Hermans EJ Eur J Psychotraumatol; 2024; 15(1):2364441. PubMed ID: 38973398 [TBL] [Abstract][Full Text] [Related]
2. Dexamethasone facilitates fear extinction and safety discrimination in PTSD: A placebo-controlled, double-blind study. Michopoulos V; Norrholm SD; Stevens JS; Glover EM; Rothbaum BO; Gillespie CF; Schwartz AC; Ressler KJ; Jovanovic T Psychoneuroendocrinology; 2017 Sep; 83():65-71. PubMed ID: 28595089 [TBL] [Abstract][Full Text] [Related]
3. Hypothalamic-pituitary-adrenal axis activity in post-traumatic stress disorder and cocaine use disorder. Hadad NA; Schwendt M; Knackstedt LA Stress; 2020 Nov; 23(6):638-650. PubMed ID: 32835581 [TBL] [Abstract][Full Text] [Related]
4. Protective effects of morphine in a rat model of post-traumatic stress disorder: Role of hypothalamic-pituitary-adrenal axis and beta- adrenergic system. Abdullahi PR; Raeis-Abdollahi E; Sameni H; Vafaei AA; Ghanbari A; Rashidy-Pour A Behav Brain Res; 2020 Oct; 395():112867. PubMed ID: 32827567 [TBL] [Abstract][Full Text] [Related]
5. The hypothalamic-pituitary-adrenal axis in PTSD: Pathophysiology and treatment interventions. Dunlop BW; Wong A Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():361-379. PubMed ID: 30342071 [TBL] [Abstract][Full Text] [Related]
6. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia. Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008727. PubMed ID: 29106702 [TBL] [Abstract][Full Text] [Related]
7. The associations of hair cortisol and DHEA with posttraumatic stress disorder symptoms in refugees. de Graaff AM; Cuijpers P; Boschloo L; Elsawy M; Hunaidy S; Seedat S; Witteveen AB; Huizink AC; Sijbrandij M; Compr Psychiatry; 2024 Feb; 129():152438. PubMed ID: 38104462 [TBL] [Abstract][Full Text] [Related]
8. Implications of hypothalamic-pituitary-adrenal axis functioning in posttraumatic stress disorder. Jones T; Moller MD J Am Psychiatr Nurses Assoc; 2011; 17(6):393-403. PubMed ID: 22142976 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trial. Dunlop BW; Rothbaum BO; Binder EB; Duncan E; Harvey PD; Jovanovic T; Kelley ME; Kinkead B; Kutner M; Iosifescu DV; Mathew SJ; Neylan TC; Kilts CD; Nemeroff CB; Mayberg HS Trials; 2014 Jun; 15():240. PubMed ID: 24950747 [TBL] [Abstract][Full Text] [Related]
10. Adulthood trauma and HPA-axis functioning in healthy subjects and PTSD patients: a meta-analysis. Klaassens ER; Giltay EJ; Cuijpers P; van Veen T; Zitman FG Psychoneuroendocrinology; 2012 Mar; 37(3):317-31. PubMed ID: 21802212 [TBL] [Abstract][Full Text] [Related]
11. Facilitating Fear-Based Memory Extinction With Dexamethasone: A Randomized Controlled Trial in Male Veterans With Combat-Related PTSD. SurĂs A; Holliday R; Adinoff B; Holder N; North CS Psychiatry; 2017; 80(4):399-410. PubMed ID: 29466111 [TBL] [Abstract][Full Text] [Related]
12. A Retrospective Study on Weaning Glucocorticoids and Recovery of the Hypothalamic-Pituitary-Adrenal Axis. Arshad MF; Elder C; Newell-Price J; Ross R; Debono M J Clin Endocrinol Metab; 2024 Oct; 109(11):e2031-e2037. PubMed ID: 38298131 [TBL] [Abstract][Full Text] [Related]
13. Stimulus-Based Extinction Generalization: Neural Correlates and Modulation by Cortisol. Hagedorn B; Wolf OT; Merz CJ Int J Neuropsychopharmacol; 2021 Apr; 24(4):354-365. PubMed ID: 33196833 [TBL] [Abstract][Full Text] [Related]
14. Cognitive effects of intravenous hydrocortisone in subjects with PTSD and healthy control subjects. Grossman R; Yehuda R; Golier J; McEwen B; Harvey P; Maria NS Ann N Y Acad Sci; 2006 Jul; 1071():410-21. PubMed ID: 16891588 [TBL] [Abstract][Full Text] [Related]
15. Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review. de Kloet CS; Vermetten E; Geuze E; Kavelaars A; Heijnen CJ; Westenberg HG J Psychiatr Res; 2006 Sep; 40(6):550-67. PubMed ID: 16214171 [TBL] [Abstract][Full Text] [Related]
16. The roles of comorbidity and trauma exposure and its timing in shaping HPA axis patterns in depression. Mayer SE; Peckins M; Kuhlman KR; Rajaram N; Lopez-Duran NL; Young EA; Abelson JL Psychoneuroendocrinology; 2020 Oct; 120():104776. PubMed ID: 32593866 [TBL] [Abstract][Full Text] [Related]
17. Effects of moderate treadmill exercise and fluoxetine on behavioural and cognitive deficits, hypothalamic-pituitary-adrenal axis dysfunction and alternations in hippocampal BDNF and mRNA expression of apoptosis - related proteins in a rat model of post-traumatic stress disorder. Shafia S; Vafaei AA; Samaei SA; Bandegi AR; Rafiei A; Valadan R; Hosseini-Khah Z; Mohammadkhani R; Rashidy-Pour A Neurobiol Learn Mem; 2017 Mar; 139():165-178. PubMed ID: 28137660 [TBL] [Abstract][Full Text] [Related]
19. Fear potentiation is associated with hypothalamic-pituitary-adrenal axis function in PTSD. Jovanovic T; Norrholm SD; Blanding NQ; Phifer JE; Weiss T; Davis M; Duncan E; Bradley B; Ressler K Psychoneuroendocrinology; 2010 Jul; 35(6):846-57. PubMed ID: 20036466 [TBL] [Abstract][Full Text] [Related]
20. Acute stress reactivity and intrusive memory development: a randomized trial using an adjusted trauma film paradigm. Hilberdink CE; de Rooij SR; Olff M; Bosch JA; van Zuiden M Psychoneuroendocrinology; 2022 May; 139():105686. PubMed ID: 35193044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]